Gavazzi Gaetan, Deffert Christine, Trocme Candice, Schäppi Michela, Herrmann François R, Krause Karl-Heinz
Department of Geriatrics, University Hospital of Grenoble, Grenoble, France.
Hypertension. 2007 Jul;50(1):189-96. doi: 10.1161/HYPERTENSIONAHA.107.089706. Epub 2007 May 14.
Oxidative stress leads to vascular damage and participates in the pathomechanisms of aortic dissection and aneurysm formation. Here we study aortic dissection in mice deficient in the superoxide-generating reduced nicotinamide-adenine dinucleotide phosphate oxidase NOX1. Seven days of treatment with the hypertensive agent angiotensin II (3 mg/kg per day) led to aortic dissection in 23% of wild-type C57BL/6J mice but in only 4% of NOX1-deficient mice (P=0.05). In contrast, treatment of wild-type C57BL/6J mice with the hypertensive agent norepinephrine (12 mg/kg per day), did not lead to aortic dissection or sudden death, suggesting that hypertension is not sufficient to cause aortic dissection. Interestingly, norepinephrine-dependent blood pressure elevations were conserved in NOX1-deficient mice, demonstrating that, different from angiotensin II, it acts through NOX1-independent hypertensive mechanisms. The resistance of NOX1-deficient mice to angiotensin II-induced aortic dissection suggests a role for NOX1-dependent alterations of the vascular wall. We, therefore, studied gene expression and protease/inhibitor equilibrium. cDNA array analysis demonstrated differential effects of angiotensin II on gene expression in wild-type and NOX1-deficient mice. Tissue inhibitor of metalloproteinase 1 was increased both on the mRNA and the protein level in aortas from NOX1-deficient mice. Thus, our results demonstrate that NOX1 is involved in the mechanisms of angiotensin II-dependent aortic dissection. As one underlying mechanism, we have identified NOX1-dependent suppression of tissue inhibitor of metalloproteinase 1 expression, which could lead to tissue damage through an altered protease/inhibitor balance.
氧化应激导致血管损伤,并参与主动脉夹层和动脉瘤形成的病理机制。在此,我们研究了超氧化物生成型还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶NOX1缺陷小鼠的主动脉夹层情况。用高血压药物血管紧张素II(每天3毫克/千克)治疗7天,导致23%的野生型C57BL/6J小鼠发生主动脉夹层,但NOX1缺陷小鼠中只有4%发生(P = 0.05)。相比之下,用高血压药物去甲肾上腺素(每天12毫克/千克)治疗野生型C57BL/6J小鼠,未导致主动脉夹层或猝死,这表明高血压不足以引起主动脉夹层。有趣的是,去甲肾上腺素依赖性血压升高在NOX1缺陷小鼠中得以保留,这表明,与血管紧张素II不同,它通过不依赖NOX1的高血压机制起作用。NOX1缺陷小鼠对血管紧张素II诱导的主动脉夹层具有抗性,这表明NOX1依赖性血管壁改变发挥了作用。因此,我们研究了基因表达以及蛋白酶/抑制剂平衡。cDNA阵列分析表明,血管紧张素II对野生型和NOX1缺陷小鼠的基因表达有不同影响。在NOX1缺陷小鼠的主动脉中,金属蛋白酶组织抑制剂1在mRNA和蛋白质水平上均增加。因此,我们的结果表明,NOX1参与了血管紧张素II依赖性主动脉夹层的机制。作为一种潜在机制,我们发现了NOX1依赖性对金属蛋白酶组织抑制剂1表达的抑制,这可能通过改变蛋白酶/抑制剂平衡导致组织损伤。
Hypertension. 2007-7
Arterioscler Thromb Vasc Biol. 2018-3-8
Circ Res. 2012-12-18
Arterioscler Thromb Vasc Biol. 2016-8
Arterioscler Thromb Vasc Biol. 2013-7-3
Physiol Rev. 2025-7-1
Antioxidants (Basel). 2024-11-27
Front Cardiovasc Med. 2024-7-12
Signal Transduct Target Ther. 2023-2-3